ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,629.00
0.55%
S&P ASX All Technology
3,016.30
1.48%
Brent Oil
82.765
0.00%
US Dollar vs AUD
1.514
0.00%
Bitcoin
63,213.74
-1.06%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Immatics NV (IMTX)

  7. Immatics NV (IMTX) News

IMTX Immatics NV

10.77
-0.12 (-1.10%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Immatics NV IMTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.12 -1.10% 10.77 07:16:11
Open Price Low Price High Price Close Price Previous Close
11.08 10.74 11.18 10.77 10.89
more quote information »

Recent News

Date Time Source Heading
21/3/202422:00GLOBEImmatics Announces Full Year 2023 Financial Results and..
23/1/202404:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/1/202400:58EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/1/202412:30GLOBEImmatics Announces Pricing of $175 Million Public Offering
18/1/202408:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/1/202408:01GLOBEImmatics Announces Proposed Public Offering
16/1/202420:06PRNUSDISCO Pharmaceuticals launches as the surfaceome company..
16/1/202419:59PRNUSDISCO Pharmaceuticals launches as the surfaceome company..
30/11/202320:00GLOBELevicept Appoints Eliot Forster as CEO
14/11/202323:00GLOBEImmatics Announces Third Quarter 2023 Financial Results and..
08/11/202323:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/11/202323:00GLOBEImmatics Reports Interim Clinical Data from ACTengine®..
24/10/202322:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/10/202322:00GLOBEImmatics Receives FDA Regenerative Medicine Advanced Therapy..
14/9/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
14/9/202307:03EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
11/9/202321:00GLOBEModerna and Immatics Announce Strategic Multi-Platform..
11/9/202320:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/8/202306:11EDGAR2Form F-3 - Registration statement by foreign private issuers
17/8/202321:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/8/202321:00GLOBEImmatics Announces Second Quarter 2023 Financial Results and..
10/8/202321:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/8/202321:00GLOBEImmatics Initiates Phase 1/2 Clinical Trial to Evaluate..
24/7/202321:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/7/202321:00GLOBEImmatics Announces $35 Million Equity Investment from..
16/5/202321:00GLOBEImmatics Announces First Quarter 2023 Financial Results and..

Your Recent History

NASDAQ
IMTX
Immatics NV
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved